the board of directors of the company inter-alia : 1. Approved the audited finacial results for the quater/year ended 31st March, 2026, 2. Reccomended a dividend @ 40% i.e., Rs 4 per ....
INDRAMEDCO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.7 pts less than Nifty Microcap 250 and 5.2 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Indraprastha Medical Corporation Limited (Apollo Hospitals, Delhi) reported audited financial results for FY 2025-26. Total income grew 9.6% to Rs. 1,511.26 crore from Rs. 1,379.01 crore in the prior year, driven by revenue from operations of Rs. 1,482.51 crore (up 9.3% YoY). Profit After Tax (PAT) rose 14% to Rs. 183.62 crore vs Rs. 160.99 crore, while EPS improved from Rs. 17.56 to Rs. 20.03 per share. The Board recommended a dividend of Rs. 4 per share (40%), down from Rs. 4.50 per share (45%) in the previous year, subject to shareholder approval at the AGM. Auditors issued an unmodified (clean) opinion, and the company is not classified as a 'Large Corporate' under SEBI norms. Cash generated from operations was Rs. 167.44 crore.
Revenue and profit growth indicate healthy operational performance. The dividend cut from Rs. 4.50 to Rs. 4 may be viewed cautiously by income-focused investors, though the improving EPS and cash generation support the company's financial stability.